Treatment with a regimen based on the experimental therapy mezigdomide reduced the risk of disease progression or death by more than 50% compared with standard…
Myeloma
I don’t think it’s any secret that I have a thing for heroes, super-powered or otherwise. Just look at the artwork for this column!…
One day last month, my mum laughed out loud at a silly joke on the comedy show she was watching on TV. The sound filled…
For World Blood Cancer Day this May 28 — a day when advocates around the globe join forces to raise awareness…
The kitchen counter used to mean Sunday mornings. I would stand there slicing up tomatoes, onions, and other vegetables. And as the sharp smell rose,…
A Phase 1 clinical trial testing the experimental therapy KLN-1010 in people with relapsed or refractory multiple myeloma has begun treating patients in the…
I used to say if I needed to take a pill every day to survive, I’d be dead in a week. So it felt like…
Some mornings, I slip into borrowed strength the way other people put on a coat. Others might wonder why I do this. After all, I’m…
Cellcentric has raised $220 million in financing to support two clinical trials testing its potentially first-in-class oral therapy inobrodib in people with hard-to-treat…
My very first journalism teacher, way back in high school, taught me the importance of “who, what, when, where, and why” as building blocks of…
Recent Posts
- As a caregiver, I’ve learned to read my mum’s daily forecast
- Short radiation course may ease painful myeloma bone lesions
- Nearly 70% of those given approved myeloma therapy alive 5 years later
- Latest AACR progress report on myeloma is a superpower of good news
- FDA green lights first-in-human study of infusion leukemia treatment